(Q34388170)

1 August 2017

title

Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

1

Stewart A. Factor

1 reference

1 August 2017

publication date

1 November 2001

1 reference

Current treatment options in neurology

1 August 2017

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

479-493

1 reference

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Does levodopa aggravate Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa: role of early treatment and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Levodopa: is toxicity a myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-001-0011-Z

Dopamine agonists: their role in the treatment of Parkinson's disease

21 January 2018

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats

1 reference

12 December 2020

Response fluctuations in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

1 reference

12 December 2020

Antioxidant properties of bromocriptine, a dopamine agonist.

1 reference

12 December 2020

Effects of bromocriptine and/or L-DOPA on neurons in substantia nigra of MPTP-treated C57BL/6 mice

1 reference

12 December 2020

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

12 December 2020

Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study

1 reference

12 December 2020

Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study

1 reference

12 December 2020

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

1 reference

12 December 2020

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

12 December 2020

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I

1 reference

12 December 2020

Long-term follow-up of early dopa treatment in Parkinson's disease

1 reference

12 December 2020

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

1 reference

12 December 2020

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

1 reference

12 December 2020

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

1 reference

12 December 2020

To treat early or to treat late?

1 reference

12 December 2020

The initial treatment of Parkinson's disease

1 reference

12 December 2020

Multi-center study of Parkinson mortality with early versus later dopa treatment

1 reference

12 December 2020

Parkinsonism treated with levodopa: progression and mortality.

1 reference

12 December 2020

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

12 December 2020

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project

1 reference

12 December 2020

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically

1 reference

12 December 2020

Oxidation reactions in Parkinson's disease.

1 reference

12 December 2020

Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group

1 reference

12 December 2020

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine

1 reference

12 December 2020

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia

1 reference

12 December 2020

Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease

1 reference

12 December 2020

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Levodopa in the treatment of Parkinson's disease: a consensus meeting

1 reference

12 December 2020

Timing of levodopa therapy

1 reference

12 December 2020

The initial treatment of Parkinson's disease should begin with levodopa

1 reference

12 December 2020

Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group

1 reference

12 December 2020

Modification of Parkinson's disease by long-term levodopa treatment

1 reference

12 December 2020

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

1 reference

12 December 2020

The free radical hypothesis in idiopathic parkinsonism: evidence against it

1 reference

12 December 2020

Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?

1 reference

12 December 2020

Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period

1 reference

12 December 2020

1 reference

12 December 2020

Nonaminergic striatal neurons convert exogenous l-dopa to dopamine in parkinsonism

1 reference

12 December 2020

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa

1 reference

12 December 2020

1 reference

12 December 2020

Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy

1 reference

12 December 2020

Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole

1 reference

12 December 2020

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

1 reference

12 December 2020

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

12 December 2020

Evidence to support early levodopa therapy in Parkinson disease

1 reference

12 December 2020

Early combination therapy with bromocriptine and levodopa in Parkinson's disease

1 reference

12 December 2020

Treatment of Parkinson's disease should begin with a dopamine agonist

1 reference

12 December 2020

Factors that influence the occurrence of response variations in Parkinson's disease

1 reference

12 December 2020

Dopamine agonists in early therapy for Parkinson disease: promise and problems

1 reference

12 December 2020

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

12 December 2020

The effect of stage of Parkinson's disease at the onset of levodopa therapy on development of motor complications

1 reference

12 December 2020

1 reference

12 December 2020

A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan

1 reference

12 December 2020

Levodopa, fertility, and longevity

1 reference

12 December 2020

Is levodopa toxic to human substantia nigra?

1 reference

12 December 2020

Adverse reactions to levodopa: drug toxicity or progression of disease?

1 reference

12 December 2020

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

12 December 2020

Mortality associated with early and late levodopa therapy initiation in Parkinson's disease

1 reference

12 December 2020

10.1007/S11940-001-0011-Z

Identifiers

DOI

1 reference

1 August 2017

1 reference